DIPLOMAT PHARMACY INC (DPLO) Stock Price, Quote, News and Overview
NYSE:DPLO - New York Stock Exchange, Inc. -
DPLO Quote, Performance and Key Statistics
4
+0.01 (+0.25%)
The current stock price of DPLO is 4 null. In the past month the price increased by 0.25%. In the past year, price decreased by -69.47%.
About DPLO
Company Profile
Diplomat Pharmacy, Inc. operates as an independent specialty pharmacy in the United States. It aids in the dispensing, delivery, dosing and reimbursement of clinically intensive and specialty drugs. The company focuses on medication management programs for people with complex chronic diseases, including oncology, immunology, hepatitis, multiple sclerosis, HIV, specialized infusion therapy and many other serious or long-term conditions. Diplomat Pharmacy, Inc. is headquartered in Flint, Michigan.
Company Info
DIPLOMAT PHARMACY INC
4100 S. SAGINAW ST.
FLINT MI 48507
CEO: Brian T. Griffin
Phone: 888-720-4450
DIPLOMAT PHARMACY INC / DPLO FAQ
What is the stock price of DIPLOMAT PHARMACY INC today?
The current stock price of DPLO is 4 null. The price increased by 0.25% in the last trading session.
What is the ticker symbol for DIPLOMAT PHARMACY INC stock?
The exchange symbol of DIPLOMAT PHARMACY INC is DPLO and it is listed on the New York Stock Exchange, Inc. exchange.
On which exchange is DPLO stock listed?
DPLO stock is listed on the New York Stock Exchange, Inc. exchange.
What is DIPLOMAT PHARMACY INC worth?
DIPLOMAT PHARMACY INC (DPLO) has a market capitalization of 304.00M null. This makes DPLO a Small Cap stock.
What are the support and resistance levels for DIPLOMAT PHARMACY INC (DPLO) stock?
DIPLOMAT PHARMACY INC (DPLO) has a support level at 4 and a resistance level at 4.01. Check the full technical report for a detailed analysis of DPLO support and resistance levels.
Should I buy DIPLOMAT PHARMACY INC (DPLO) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of DPLO, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of DPLO, evaluating the profitability, health, valuation and growth aspects
- DIPLOMAT PHARMACY INC (DPLO) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- DIPLOMAT PHARMACY INC (DPLO) Sales and EPS estimates to see what analysts future expectations are.
- DIPLOMAT PHARMACY INC (DPLO) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- DIPLOMAT PHARMACY INC (DPLO) Insider and Institutional Ownership to learn about the owners and their transactions.
- DIPLOMAT PHARMACY INC (DPLO) Stock Chart to make your own analysis
- DIPLOMAT PHARMACY INC (DPLO) Latest news and press-releases to stay up to date.
Does DIPLOMAT PHARMACY INC (DPLO) stock pay dividends?
DPLO does not pay a dividend.
What is the Price/Earnings (PE) ratio of DIPLOMAT PHARMACY INC (DPLO)?
DIPLOMAT PHARMACY INC (DPLO) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.54).
DPLO Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to DPLO. When comparing the yearly performance of all stocks, DPLO is a bad performer in the overall market: 97.95% of all stocks are doing better.
DPLO Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to DPLO. DPLO has a bad profitability rating. Also its financial health evaluation is rather negative.
DPLO Financial Highlights
Over the last trailing twelve months DPLO reported a non-GAAP Earnings per Share(EPS) of -0.5399999999999999. The EPS decreased by -198.18% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -12.47% | ||
| ROA | -55.83% | ||
| ROE | N/A | ||
| Debt/Equity | 0.18 |
DPLO Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 56% to DPLO. The Buy consensus is the average rating of analysts ratings from 10 analysts.